Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone
This study is currently recruiting participants.
Study NCT00545129   Information provided by Pfizer
First Received: October 15, 2007   Last Updated: November 4, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neoplasm Metastasis
Palliative Care
Additional conditions recognized in this trial
Neoplasms
More general conditions related to this trial
Neoplastic Processes
Pathologic Processes
Interventions listed in this trial
Tanezumab 10 mg IV
IV Placebo for tanezumab
Additional drug interventions recognized in this trial
Analgesics, Opioid
More general drug interventions related to this trial
Analgesics
Central Nervous System Agents
Central Nervous System Depressants
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services